Karo Healthcare has appointed Philip Hampden-Smith as its new Chief Operations Officer starting Q4 2026. Philip brings 20 years of global experience in operations and supply chain leadership, previously holding senior roles at Reckitt. His expertise in operational transformation and cost reduction is expected to strengthen Karo's capabilities and support its growth strategy. He replaces Jonathan Kimber, who played a key role in building Karo's operations and M&A integration over the past decade.
Cybersecurity stocks rallied strongly following better-than-expected Q2 2027 earnings reports from Okta and CrowdStrike. Okta's shares jumped 22% after reporting $805 million in revenue and positioning itself as a key security layer for AI agents, wh...
Ethena's ENA token surged about 25% since Aug. 21, peaking near $0.18 on Aug. 23 before pulling back to around $0.147 amid profit-taking. The rally was driven by a new $1 billion secured lending facility with FalconX, enabling institutional loans bac...
Target reported a strong Q2 fiscal 2027 with 5.27% revenue growth and rising store traffic, driving a 78% share price increase in 2025. Despite this, Wall Street remains skeptical, with many analysts holding or selling the stock. The company raised i...
Blast Resources Inc. has appointed Andy Yackulic, a seasoned uranium exploration executive with over 20 years of experience, to its board of directors. Yackulic's expertise, including leadership roles at Denison Mines and Cameco, is expected to enhan...
Lunai Bioworks, an AI-driven precision medicine company, filed a Second Amended Complaint in U.S. District Court accusing six registered broker-dealers and two principals of securities fraud and market manipulation. This legal action expands the list...
